Datinvest International Ltd. (TSXV:DAI.H) announced a private placement through issuance of subscription receipts at CAD 0.45 per receipt for gross proceeds of not less than CAD 4 million on May 18, 2018. The company has signed a letter of intent to have private placement to acquire all of the issued and outstanding share capital of Exxel Pharma Inc. Each receipt will automatically be converted into one unit of the company. Each unit will consist of one common share of the company and one common share purchase warrant entitling the holder to acquire an additional common share at a price of CAD 0.90 for a period of twenty-four months.